那他霉素联合氟康唑治疗真菌性角膜炎的临床疗效研究
The Clinical Effectiveness of a Combination of Natamycin and Fluconazole in Treating Fungal Keratitis
DOI: 10.12677/ACM.2023.1361366, PDF,   
作者: 杨绪广, 丛 凡, 李 翠*:青岛大学附属医院眼科,山东 青岛
关键词: 真菌性角膜炎那他霉素氟康唑Meta-分析Fungal Keratitis Natamycin Fluconazole Meta-Analysis
摘要: 目的:本研究旨在系统性地评估那他霉素和氟康唑联合治疗真菌性角膜炎的临床疗效,以期为真菌性角膜炎的临床治疗提供有力的参考依据。方法:通过计算机检索,从知网(CNKI)、维普网(VIP)、万方数据库、Pubmed、Web of Science (WOS)和Cochrane Library数据库中,检索出从2000年1月到2022年1月期间联合应用那他霉素和氟康唑治疗真菌性角膜炎的随机对照实验,并根据排除或纳入标准,筛选出有效数据,最终进行Meta-分析。将联合应用那他霉素和氟康唑组视为实验组,将单独应用那他霉素或氟康唑组视为对照组。结果:共纳入8个RCT,样本总数714例,其中实验组361例,对照组353例。Meta-分析结果:在治疗真菌性角膜炎方面,实验组的有效率(OR = 3.66, 95% CI: 2.27~5.91, Z = 5.31, P < 0.00001)和显效率(OR = 2.29, 95% CI: 1.68~3.13, Z = 5.24, P < 0.00001)均高于对照组。结论:那他霉素和氟康唑联合应用治疗真菌性角膜炎疗效好于单独使用氟康唑或那他霉素。
Abstract: Objective: To evaluate the clinical effectiveness of combination therapy of natamycin and flucona-zole in treatment of fungal keratitis, providing reference for the combined use of natamycin and fluconazole incurring fungal keratitis. Methods: Obliged with the standard of inclusion and exclu-sion criteria, randomized controlled trials (RCTs) about combined treatment of natamycin and flu-conazole for fungal keratitis from January 1st, 2000 to January 1st, 2022 were selected from CNKI, VIP, Wanfang, Pubmed, Web of Science and Cochrane Library through computer retrieval. Accord-ing to the exclusion or inclusion criteria, the valid data were screened out, and finally meta-analysis was performed. The groups of combined use of natamycin and fluconazole were defined as experi-mental group and the groups of single use of natamycin or fluconazole were defined as control groups. Results: 8 RCTs including 361 experimental cases and 353 control cases (totally 714 cases) were selected. The efficacy (OR = 3.66, 95% CI: 2.27~5.91, Z = 5.31, P < 0.00001) and marked effi-cacy (OR = 2.29, 95% CI: 1.68~3.13, Z = 5.24, P < 0.00001) of the combination of natamycin and flu-conazole in treating fungal keratitis was superior to that of the single application of either drug. Conclusion: The combined use of natamycin and fluconazole was more effective than the single use of natamycin or fluconazole in treatment of fungal keratitis.
文章引用:杨绪广, 丛凡, 李翠. 那他霉素联合氟康唑治疗真菌性角膜炎的临床疗效研究[J]. 临床医学进展, 2023, 13(6): 9757-9765. https://doi.org/10.12677/ACM.2023.1361366

参考文献

[1] Sharma, N., Bagga, B., Singhal, D., Nagpal, R., Kate, A., Saluja, G., et al. (2022) Fungal Keratitis: A Review of Clinical Presentations, Treatment Strategies and Outcomes. The Ocular Surface, 24, 22-30. [Google Scholar] [CrossRef] [PubMed]
[2] Cullen, M., Jacob, M.E., Cornish, V., VanderSchel, I.Q., Cotter, H.V.T., Cubeta, M.A., et al. (2019) Multi-Locus DNA Sequence Analysis, Antifungal Agent Susceptibility, and Fungal Keratitis Outcome in Horses from Southeastern United States. PLOS ONE, 14, e0214214. [Google Scholar] [CrossRef] [PubMed]
[3] 陈金鹏, 汪荣, 徐辉勇, 等. 两种手术方式治疗真菌性角膜炎的临床观察[J]. 中国真菌学杂志, 2014, 9(1): 36-38+46.
[4] Gu, L., Lin, J., Wang, Q., Li, C., Peng, X., Fan, Y., et al. (2020) Dimethyl Itaconate Protects against Fungal Keratitis by Activating the Nrf2/HO-1 Signaling Pathway. Im-munology & Cell Biology, 98, 229-241. [Google Scholar] [CrossRef] [PubMed]
[5] Suriyaamporn, P., Opanasopit, P., Rangsimawong, W. and Ngawhirunpat, T. (2022) Optimal Design of Novel Microemulsions-Based Two-Layered Dissolving Microneedles for Delivering Flu-conazole in Treatment of Fungal Eye Infection. Pharmaceutics, 14, Article No. 472. [Google Scholar] [CrossRef] [PubMed]
[6] Pandey, M., Choudhury, H., et al. (2021) Potential of Stimu-li-Responsive in Situ Gel System for Sustained Ocular Drug Delivery: Recent Progress and Contemporary Research. Polymers (Basel), 13, Article No. 1340. [Google Scholar] [CrossRef] [PubMed]
[7] Thomas, P.A. (2003) Current Perspectives on Ophthalmic Mycoses. Clinical Microbiology Reviews, 16, 730-797. [Google Scholar] [CrossRef
[8] 祝彩英. 那他霉素联合氟康唑治疗真菌性角膜炎的疗效评比[J]. 中外医学研究, 2015, 13(4): 45-46.
[9] 郭桂芬. 那他霉素合氟康唑滴眼液治疗真菌性角膜溃疡37例临床观察[J]. 中国民族民间医药, 2015(6): 106.
[10] 李丹红. 那他霉素联合氟康唑及碘酊烧灼治疗真菌性角膜溃疡的临床研究[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2010.
[11] 刘倩. 氟康唑胶囊联合那他霉素滴眼液治疗真菌性角膜炎的疗效观察[J]. 饮食保健, 2020(39): 60.
[12] 卢建麟. 那他霉素联合氟康唑治疗真菌性角膜炎的疗效观察[J]. 中国保健营养, 2018, 28(3): 271.
[13] 田进山, 马正娟, 马梦凯. 那他霉素(5%)、氟康唑(0.2%)联合治疗真菌性角膜炎效果分析[J]. 心理医生, 2016, 22(28): 126-127.
[14] 王效武, 原莉莉, 李冰. 那他霉素联合氟康唑治疗真菌性角膜溃疡临床分析[J]. 山西医药杂志, 2007, 36(5): 253-254.
[15] 姚丽娟, 邢景景. 氟康唑胶囊联合那他霉素滴眼液治疗82例真菌性角膜炎的疗效观察[J]. 北方药学, 2019, 16(5): 127-128.
[16] O’Day, D.M., Head, W.S., Robinson, R.D., et al. (1986) Corneal Penetration of Topical Amphotericin B and Natamycin. Current Eye Research, 5, 877-882. [Google Scholar] [CrossRef] [PubMed]
[17] El-Houssaini, H.H., Elnabawy, O.M., Nasser, H.A. and Elkhatib, W.F. (2019) Influence of Subinhibitory Antifungal Concentrations on Extracellular Hydrolases and Biofilm Production by Candida Albicans Recovered from Egyptian Patients. BMC Infec-tious Diseases, 19, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[18] Saluja, G., Sharma, N., Agarwal, R., Sharma, H.P., Singhal, D., Kumar Maharana, P., et al. (2021) Comparison of Safety and Efficacy of In-trastromal Injections of Voriconazole, Amphotericin B and Natamycin in Cases of Recalcitrant Fungal Keratitis: A Ran-domized Controlled Trial. Clinical Ophthalmology, 15, 2437-2446. [Google Scholar] [CrossRef
[19] Yee, R.W., Cheng, C.J., Meenakshi, S., et al. (1997) Ocular Penetra-tion and Pharmacokinetics of Topical Fluconazole. Cornea, 16, 64-71. [Google Scholar] [CrossRef
[20] O’Day, D.M., Foulds, G., Williams, T.E., et al. (1990) Ocular Uptake of Fluconazole Following Oral Administration. Archives of Ophthalmology, 108, 1006-1008. [Google Scholar] [CrossRef] [PubMed]
[21] Diongue, K., Ndiaye, M., Seck, M.C., et al. (2017) Onychomycosis Caused by Fusarium spp. in Dakar, Senegal: Epidemiological, Clinical, and Mycological Study. Der-matology Research and Practice, 2017, Article ID: 1268130. [Google Scholar] [CrossRef] [PubMed]